Dr. Druley discusses novel technologies to detect minimal residual disease (MRD) at the American Society of Hematology (ASH) Congress 2016 in San Diego, CA.
Todd E. Druley, MD, from the Washington University School of Medicine in St. Louis, St. Louis, MO, discusses novel technologies to detect minimal residual disease (MRD) at the American Society of Hematology (ASH) Congress 2016 in San Diego, CA. He explains that minimal residual disease (MRD) is the assessment for residual leukemia after a patient […]
Kellsie’s Hope Foundation sponsored their 5th annual Trees of Hope Gala on November 19th in memory of Kellsie Marchbanks (a former patient of Dr. Druleys) and so many other children who have lost their fight with cancer. The Druley lab was well represented and incredibly honored to receive a donation of $100,000 to support their […]
Dr. Druley is a pediatric oncologist who is focused on the genetic causes of cancer in children and is most rewarded by helping both families and patients through treatment.
The National Cancer Institute awarded the Druley Lab a 5-year RO1 award to apply Error-Corrected Sequencing (ECS) to study children with de novo acute myeloid leukemia (AML). In collaboration with the Children’s Oncology Group, we will apply ECS to characterize approximately 2,000 samples from children treated in the largest AML study ever performed in North America. Results […]